Correction: Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis

• Mahnoor Mir,
• Felipe Soto,
• Pedro Antonio Amezcua Gomez,
• Rodrigo Del Rio Arroyo,
• Adarsh Suresh,
• Amber Su,
• Qiong Gan,
• John Stewart,
• Roberto Adachi,
• Diwakar D. Balachandran,
• Lara Bashoura,
• Roberto F. Casal,
• Burton F. Dickey,
• George A. Eapen,
• Scott E. Evans,
• Horiana Grosu,
• Carlos A. Jimenez,
• Julie Lin,
• David E. Ost,
• Bruce F. Sabath,
• Vickie R. Shannon,
• Aung Naing,
• Jianjun Gao,
• Jia Wu,
• Karthik Suresh,
• Saadia A. Faiz,
• Mehmet Altan,
• Ajay Sheshadri

Affiliations

Mahnoor Mir

Division of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School at UTHealth Houston, Houston, TX, United States

Felipe Soto

School of Medicine, Tecnológico de Monterrey, Monterrey, Mexico

Pedro Antonio Amezcua Gomez

School of Medicine, Tecnológico de Monterrey, Monterrey, Mexico

Rodrigo Del Rio Arroyo

School of Medicine, Tecnológico de Monterrey, Monterrey, Mexico

Adarsh Suresh

Texas A&M School of Medicine, Houston, TX, United States

Amber Su

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Qiong Gan

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

John Stewart

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Roberto Adachi

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Diwakar D. Balachandran

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Lara Bashoura

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Roberto F. Casal

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Burton F. Dickey

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

George A. Eapen

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Scott E. Evans

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Horiana Grosu

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Carlos A. Jimenez

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Julie Lin

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

David E. Ost

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Bruce F. Sabath

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Vickie R. Shannon

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Aung Naing

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Jianjun Gao

Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Houston, TX, United States

Jia Wu

Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Karthik Suresh

Department of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States

Saadia A. Faiz

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Mehmet Altan

0Department of Thoracic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Ajay Sheshadri

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States